These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

932 related items for PubMed ID: 18813885

  • 1. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L, Schlitt A, Faerber J, Bond SP, Messow CM, Buerke M, Raaz U, Werdan K, Muenzel T, Weiss C.
    Med Klin (Munich); 2008 Sep 15; 103(9):628-32. PubMed ID: 18813885
    [Abstract] [Full Text] [Related]

  • 2. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.
    Sarafoff N, Ndrepepa G, Mehilli J, Dörrler K, Schulz S, Iijima R, Byrne R, Schömig A, Kastrati A.
    J Intern Med; 2008 Nov 15; 264(5):472-80. PubMed ID: 18624903
    [Abstract] [Full Text] [Related]

  • 3. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ, ACTIVE W Investigators.
    J Am Coll Cardiol; 2007 Nov 27; 50(22):2156-61. PubMed ID: 18036454
    [Abstract] [Full Text] [Related]

  • 4. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.
    Pharmacotherapy; 2007 May 27; 27(5):691-6. PubMed ID: 17461704
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
    Baber U, Akhter M, Kothari S, Sharma SK, Kini A.
    J Invasive Cardiol; 2010 Feb 27; 22(2):80-3. PubMed ID: 20124594
    [Abstract] [Full Text] [Related]

  • 6. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM, Marín F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Valdés M, Lip GY.
    J Am Coll Cardiol; 2008 Feb 26; 51(8):818-25. PubMed ID: 18294566
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB.
    Am Heart J; 2004 Mar 26; 147(3):463-7. PubMed ID: 14999195
    [Abstract] [Full Text] [Related]

  • 8. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M, Gislason GH, Olesen JB, Kristensen SL, Schjerning Olsen AM, Mikkelsen A, Christensen CB, Lip GY, Køber L, Torp-Pedersen C, Hansen ML.
    J Am Coll Cardiol; 2013 Sep 10; 62(11):981-9. PubMed ID: 23747760
    [Abstract] [Full Text] [Related]

  • 9. Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel.
    Pasceri V, Patti G, Pristipino C, Pelliccia F, Irini D, Varveri A, Roncella A, Di Sciascio G, Speciale G.
    Catheter Cardiovasc Interv; 2010 May 01; 75(6):936-42. PubMed ID: 20146326
    [Abstract] [Full Text] [Related]

  • 10. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
    Dosh K, Berger PB, Marso S, van Lente F, Brennan DM, Charnigo R, Topol EJ, Steinhubl S.
    Circ Cardiovasc Interv; 2009 Dec 01; 2(6):503-12. PubMed ID: 20031767
    [Abstract] [Full Text] [Related]

  • 11. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G, Gilard M, Le Feuvre C, Zaman AG.
    Nat Clin Pract Cardiovasc Med; 2006 Dec 01; 3(12):673-80. PubMed ID: 17122800
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dilemma of antithrombotic therapy in anticoagulated atrial fibrillation patients squeezed between thrombosis and bleeding events: a single-centre experience.
    Halbfass P, Janko S, Dorwarth U, Riess G, Antoni D, Hoffmann E.
    Europace; 2009 Jul 01; 11(7):957-60. PubMed ID: 19493910
    [Abstract] [Full Text] [Related]

  • 14. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB, Wiviott SD, Buros JL, Zorkun C, Tariq MU, Antman EM, Braunwald E, Gibson CM, TIMI Study Group.
    Am Heart J; 2009 Sep 01; 158(3):e21-6. PubMed ID: 19699846
    [Abstract] [Full Text] [Related]

  • 15. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L, Fauchier L, Nonin E, de Labriolle A, Haguenoer K, Cosnay P, Babuty D, Charbonnier B.
    Thromb Haemost; 2010 Apr 01; 103(4):833-40. PubMed ID: 20135077
    [Abstract] [Full Text] [Related]

  • 16. Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).
    Dewilde W, Berg JT.
    Am Heart J; 2009 Nov 01; 158(5):713-8. PubMed ID: 19853687
    [Abstract] [Full Text] [Related]

  • 17. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.
    Thromb Haemost; 2010 Dec 01; 104(6):1211-8. PubMed ID: 20941464
    [Abstract] [Full Text] [Related]

  • 18. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A, Amit G, Cafri C, Gilutz H, Ilia R, Zahger D.
    Int J Cardiol; 2005 Sep 01; 103(3):293-7. PubMed ID: 16098392
    [Abstract] [Full Text] [Related]

  • 19. Rationale for low-molecular weight heparin in coronary stenting.
    Zidar JP.
    Am Heart J; 1997 Nov 01; 134(5 Pt 2):S81-7. PubMed ID: 9396639
    [Abstract] [Full Text] [Related]

  • 20. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX.
    Thromb Res; 2009 May 01; 124(1):46-51. PubMed ID: 19041120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.